CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2016; 07(02): 080-082
DOI: 10.4103/0976-5042.189163
Case Report
Journal of Digestive Endoscopy

Pancreatic neuroendocrine tumor masquerading as metastasis in a patient with esophageal cancer: Diagnosis by endoscopic ultrasound-guided fine-needle aspiration

Pramoda Koduru
Department of Gastroenterology, Hepatology and Nutrition, University of Texas MD Anderson Cancer Center,
,
Shruti Khurana
1   Department of Gastroenterology, Hepatology and Nutrition, University of Texas Health Science Center,
,
Joan B. Gornals
2   Department of Digestive Diseases, Endoscopy Unit, Hospital Universitari de Bellvitge-IDIBELL,
,
Modesto Varas
3   Centro Médico Teknon and Hospital Universitario del Valle Hebrón, Unit of Echoendoscopy, Barcelona, Spain
,
Sinchita Roy-Chowdhuri
4   Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA,
,
Manoop S. Bhutani
Department of Gastroenterology, Hepatology and Nutrition, University of Texas MD Anderson Cancer Center,
› Author Affiliations
Further Information

Publication History

Publication Date:
26 September 2019 (online)

Abstract

The role of endoscopic ultrasound (EUS) and guided biopsies has been well established for the locoregional staging of esophageal cancers. However, their role in posttreatment surveillance is unclear. Here, we describe a case of a pancreatic mass diagnosed on the follow-up positron emission tomography scan, concerning for a metastatic lesion. EUS-guided fine-needle aspiration (FNA) helped in establishing the diagnosis of neuroendocrine tumor, which tends to have a similar sonographic appearance. Therefore, it is imperative to evaluate a suspicious mass seen on computed tomography/positron emission tomography scan. EUS and EUS-guided FNA can serve as useful modalities to confirm the diagnosis by cytopathology.

 
  • References

  • 1 van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD. Staging investigations for oesophageal cancer: A meta-analysis. Br J Cancer 2008;98:547-57.
  • 2 Foley KG, Lewis WG, Fielding P, Karran A, Chan D, Blake P, et al. N-staging of oesophageal and junctional carcinoma: Is there still a role for EUS in patients staged N0 at PET/CT? Clin Radiol 2014;69:959-64.
  • 3 Misra S, Choi M, Livingstone AS, Franceschi D. The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer. Surg Endosc 2012;26:518-22.
  • 4 Gri-n JM, Reed CE, Denlinger CE. Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer. Ann Thorac Surg 2012;93:1855-9.
  • 5 Esfehani MH, Mahmoodzadeh H, Alibakhshi A, Safavi F. Esophageal squamous cell carcinoma with pancreatic metastasis: A case report. Acta Med Iran 2011;49:760-2.
  • 6 Gornals J, Varas M, Catalá I, Maisterra S, Pons C, Bargalló D, et al. Definitive diagnosis of neuroendocrine tumors using fine-needle aspiration-puncture guided by endoscopic ultrasonography. Rev Esp Enferm Dig 2011;103:123-8.
  • 7 Atiq M, Bhutani MS, Ross WA, Raju GS, Gong Y, Tamm EP, et al. Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: A tertiary cancer center experience. Pancreas 2013;42:516-23.
  • 8 Ekeblad S, Skogseid B, Dunder K, Oberg K, Eriksson B. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 2008;14:7798-803.
  • 9 Khashab MA, Yong E, Lennon AM, Shin EJ, Amateau S, Hruban RH, et al. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. Gastrointest Endosc 2011;73:691-6.
  • 10 Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, et al. EUS-FNA for pancreatic neuroendocrine tumors: A tertiary cancer center experience. Dig Dis Sci 2012;57:791-800.